FDA Approves Sotorasib with Panitumumab for KRAS G12C-mutated Colorectal Cancer By Ogkologos - February 13, 2025 715 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CodeBreaK 300 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR 9 Ways to Use Social Media for Support Throughout Your Cancer... February 4, 2021 New Vaccine Stimulates Survivors’ Immune Systems to Keep Triple-Negative Cancer from... February 14, 2020 Brentuximab Approved for High-Risk Hodgkin Lymphoma in Children and Adolescents December 15, 2022 BRCA1/2 Pathogenic Variant Carriers with Serous Tubal Intraepithelial Carcinoma at Risk-Reducing... April 4, 2022 Load more HOT NEWS Creating a shared vision to detect cancer earlier Significantly Longer PFS with First-line Pembrolizumab for MSI-H/dMMR mCRC ¿Puede una biopsia hacer que mi cáncer se disemine? TMB Consortium Develops a TMB Calibration Tool
